Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001398344-25-011237·Stablecoin Development Corp
Schedule 13D ownership disclosure
NovaBay Pharmaceuticals Inc
Common Stock, par value $0.01 per share · CUSIP: 66987P409
Event date: 2025-06-03
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Poplar Point Capital Management LLCReported CIK 0001588273
Shares: 1,020,300.00 · Class: 17.54%
- Poplar Point Capital Partners LPReported CIK 0001588289
Shares: 1,020,300.00 · Class: 17.54%
- Poplar Point Capital GP LLCReported CIK 0001588288
Shares: 1,020,300.00 · Class: 17.54%
- Jad FakhryReported CIK 0001588217
Shares: 1,020,300.00 · Class: 17.54%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001398344-25-011237
- Form type
- SCHEDULE 13D
- Filer
- Stablecoin Development Corp
- CIK
- CIK 1389545
- Filed
- Jun 04, 2025
- Reporting period
- Jun 03, 2025
- Description
- Schedule 13D beneficial ownership